The Long-Acting D3 Partial Agonist MC-25-41 Attenuates Motivation for Cocaine in Sprague-Dawley Rats

The role of orexin-1 receptor signaling in demand for the opioid fentanyl

(2019) Jennifer E. Fragale et al.   NEUROPSYCHOPHARMACOLOGY

Design, synthesis, and evaluation of N-(4-(4-phenyl piperazin-1-yl)butyl)-4-(thiophen-3-yl)benzamides as selective dopamine D3 receptor ligands

(2019) Peng-Jen Chen et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Dopamine D1 and D3 receptor polypharmacology as a potential treatment approach for substance use disorder

(2018) Ewa Galaj et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects

(2018) Zhi-Bing You et al.   NEUROPSYCHOPHARMACOLOGY

NIDA’s medication development priorities in response to the Opioid Crisis: ten most wanted

(2018) Kurt Rasmussen et al.   NEUROPSYCHOPHARMACOLOGY

Dopamine D3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors

(2018) Gregory L. Powell et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity

(2017) Leonardo Bontempi et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Effects of Acute and Chronic Treatments with Dopamine D 2 and D 3 Receptor Ligands on Cocaine versus Food Choice in Rats

(2017) Morgane Thomsen et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

The dopamine D3 receptor, a quarter century later

(2016) Pierre Sokoloff et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Dopamine D3 receptor knockout mice exhibit abnormal nociception in a sex-different manner

(2016) Peng Liu et al.   JOURNAL OF NEUROSCIENCE RESEARCH

The 5-HT 2C receptor agonist lorcaserin reduces cocaine self-administration, reinstatement of cocaine-seeking and cocaine induced locomotor activity

(2016) Colin Harvey-Lewis et al.   NEUROPHARMACOLOGY

Effect of a D3 receptor antagonist on context-induced reinstatement of nicotine seeking

(2016) Pamela Sabioni et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Individual differences in orexin-I receptor modulation of motivation for the opioid remifentanil

(2015) Kirsten A. Porter-Stransky et al.   ADDICTION BIOLOGY

Orexin-1 receptor signaling increases motivation for cocaine-associated cues

(2015) Brandon S. Bentzley et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Dopamine receptor partial agonists and addiction

(2015) Fabricio A. Moreira et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

A modified exponential behavioral economic demand model to better describe consumption data.

(2015) Mikhail N. Koffarnus et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis

(2015) Thomas M. Keck et al.   JOURNAL OF MEDICINAL CHEMISTRY

The Behavioral Economics of Substance Use Disorders: Reinforcement Pathologies and Their Repair

(2014) Warren K. Bickel et al.   Annual Review of Clinical Psychology

Economic demand predicts addiction-like behavior and therapeutic efficacy of oxytocin in the rat

(2014) B. S. Bentzley et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development

(2013) Janet L. Neisewander et al.   NEUROPHARMACOLOGY

Medication discovery for addiction: Translating the dopamine D3 receptor hypothesis

(2012) Amy Hauck Newman et al.   BIOCHEMICAL PHARMACOLOGY

Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in rats

(2012) T.H.C. Cheung et al.   NEUROPHARMACOLOGY

The behavioral economics of drug self-administration: A review and new analytical approach for within-session procedures

(2012) Brandon S. Bentzley et al.   PSYCHOPHARMACOLOGY

YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice

(2011) Rui Song et al.   ADDICTION BIOLOGY

Dopamine D3 receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats

(2011) Amanda E. Higley et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access

(2010) Laura Orio et al.   ADDICTION BIOLOGY

Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders

(2010) Christian A. Heidbreder et al.   Annals of the New York Academy of Sciences

Stimulation of Medial Prefrontal Cortex Serotonin 2C (5-HT2C) Receptors Attenuates Cocaine-Seeking Behavior

(2010) Nathan S Pentkowski et al.   NEUROPSYCHOPHARMACOLOGY

A novel IV cocaine self-administration procedure in rats: differential effects of dopamine, serotonin, and GABA drug pre-treatments on cocaine consumption and maximal price paid

(2010) Erik B. Oleson et al.   PSYCHOPHARMACOLOGY

The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys

(2009) Cindy Achat-Mendes et al.   PSYCHOPHARMACOLOGY

c-Fos expression associated with reinstatement of cocaine-seeking behavior by response-contingent conditioned cues

(2009) Peter R. Kufahl et al.   SYNAPSE

The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy

(2008) Art Van Zee   AMERICAN JOURNAL OF PUBLIC HEALTH

Behavioral Economic Assessment of Price and Cocaine Consumption Following Self-Administration Histories that Produce Escalation of Either Final Ratios or Intake

(2008) Erik B Oleson et al.   NEUROPSYCHOPHARMACOLOGY